A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by …

H Mohammed, DD Pham-Tran, ZYM Yeoh, B Wang… - Vaccines, 2023 - mdpi.com
Real-world data on the effectiveness of COVID-19 vaccines against the Omicron variant (B.
1.1. 529) is limited. This systematic review aimed to investigate the real-world effectiveness …

mRNA vaccines against SARS-CoV-2: Advantages and caveats

M Echaide, L Chocarro de Erauso… - International Journal of …, 2023 - mdpi.com
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …

Emerging SARS-CoV-2 variants and subvariants: challenges and opportunities in the context of COVID-19 pandemic

S Rahman, MJ Hossain, Z Nahar… - Environmental …, 2022 - journals.sagepub.com
The COVID-19 pandemic has become the most devastating pandemic of the 21st century
since its appearance in December 2019. Like other RNA viruses, continuous mutation is …

SARS‐CoV‐2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control

EFSA Panel on Animal Health and Welfare … - EFSA …, 2023 - Wiley Online Library
The epidemiological situation of SARS‐CoV‐2 in humans and animals is continually
evolving. To date, animal species known to transmit SARS‐CoV‐2 are American mink …

Efficacy of a bivalent (D614+ B. 1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind …

GH Dayan, N Rouphael, SR Walsh, A Chen… - The Lancet …, 2023 - thelancet.com
Background COVID-19 vaccines with alternative strain compositions are needed to provide
broad protection against newly emergent SARS-CoV-2 variants of concern. This study …

COVID-19 vaccination did not increase the risk of potentially related serious adverse events: 18-month cohort study in an Italian province

ME Flacco, C Acuti Martellucci, G Soldato, G Di Martino… - Vaccines, 2022 - mdpi.com
This cohort study on the entire population of an Italian Province assessed the incidence of
potentially vaccine-related serious adverse events (PVR-SAEs) by COVID-19 vaccination …

Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis

MO Rahman, T Kamigaki, MM Thandar, R Haruyama… - BMJ open, 2023 - bmjopen.bmj.com
Objectives The rapid spread of the SARS-CoV-2 Omicron variant has raised concerns
regarding waning vaccine-induced immunity and durability. We evaluated protection of the …

Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities

MS Alam - Heliyon, 2023 - cell.com
The Omicron, the latest variant of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), was first detected in November 2021 in Botswana, South Africa. Compared to other …

[PDF][PDF] Chocarro de Erauso

M Echaide - Bocanegra, A., Blanco, E., Kochan, G. and …, 2023 - academica-e.unavarra.es
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …

Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach

B Majeed, JF David, NL Bragazzi, Z McCarthy… - Frontiers in Public …, 2023 - frontiersin.org
The co-circulation of two respiratory infections with similar symptoms in a population can
significantly overburden a healthcare system by slowing the testing and treatment. The …